Skip to content

Caffeinate Chewing Gum on Ice Hockey Performance

The Effect of Caffeinate Chewing Gum on Ice Hockey Performance After Partial Sleep Deprivation: a Double-blind Crossover Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06557655
Enrollment
14
Registered
2024-08-16
Start date
2024-02-05
Completion date
2024-04-30
Last updated
2024-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caffeine, Placebo

Keywords

exercise performance, fatigue index

Brief summary

The purpose of this study was to examine the impact of caffeinated chewing gum on the physical performance of elite ice hockey players in a partial sleep deprivation state.

Detailed description

This study used a randomisation crossover design with a single-blind, double-blind experimental design. The participants were randomly assigned to either a caffeinated chewing gum trial (CAF) or a placebo trial (PL).

Interventions

DIETARY_SUPPLEMENTcaffeinate chewing gum

participants either chewed caffeinated gum (CAF) containing 3 mg/kg caffeine or a caffeine-free placebo gum (PLA) for 10 minutes prior to undertaking a series of tests on-ice and off-ice.

Sponsors

National Taiwan Sport University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

The order of participants was determined through the use of computerized randomization software

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 1\. 6 years of professional ice hockey training, * 2\. 6 months of continuous training, * 3\. 3 months of recovery from sports injuries such as strains and sprains

Exclusion criteria

* 1\. non-specialised ice hockey player. * 2\. has not trained regularly for the past 6 months. * 3\. has recovered from an athletic injury. * 4\. have been recovering from a sports injury for less than 3 months, or have epilepsy, hypertension, hyperlipidemia, heart disease, arthritis, osteoporosis, brain injury, or a history of caffeine allergy.

Design outcomes

Primary

MeasureTime frameDescription
counter-movement jump15 minutes after interventionjump height

Secondary

MeasureTime frameDescription
35-metre sprint15 minutes after interventioncomplete time (seconds)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026